• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
TYP

TRYPTAMINE THERAPEUTICS LIMITED

6.25% ! 3.4¢
Market Cap $47.24M  !

Tryptamine Therapeutics Limited is an Australia-based clinical-stage biotechnology... Tryptamine Therapeutics Limited is an Australia-based clinical-stage biotechnology company. The Company is focused on developing proprietary, novel formulations for the administration of psilocin in combination with psychotherapy to treat diseases with unmet medical needs. It is focused on bringing transformative medicine with known safety profiles to diseases with no effective first-line treatments. Its lead program, TRP-8803, is a proprietary formulation of IV-infused psilocin (the active metabolite of psilocybin) with potential to alleviate numerous shortcomings of oral psilocybin It intends to accomplish this through the development of an IV infusion of psilocin Its lead programs are designed to address neuropsychiatric disorders through the therapeutic dosing of synthetic psilocybin and IV infused psilocin in conjunction with psychotherapy. It has completed phase II clinical trials for the treatment of binge eating disorder. Its pipeline products include TRP-8803 and TRP-8802.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
TYP
TYP Charts
2
30/08/25 61 26K
30/08/25 Last post  atomik Comments Created with Sketch.  61  Views Created with Sketch.  26K 
TYP 29/08/25 0 112
29/08/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  112 
TYP 29/08/25 0 119
29/08/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  119 
TYP
TYP - Media & News
28/08/25 49 26K
28/08/25 Last post  dsa69 Comments Created with Sketch.  49  Views Created with Sketch.  26K 
TYP 26/08/25 3 813
26/08/25 Last post  IndexInvestor Comments Created with Sketch.  3  Views Created with Sketch.  813 
TYP 21/08/25 0 185
21/08/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  185 
TYP 13/08/25 0 306
13/08/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  306 
TYP 12/08/25 9 2.1K
12/08/25 Last post  BoZz Comments Created with Sketch.  9  Views Created with Sketch.  2.1K 

See All Discussions arrow Created with Sketch.

Timeline

Appendix 4G and Corporate Governance Statement
29 Aug 09:05
 
Appendix 4E and 2025 Annual Report
29 Aug 08:52
 
Proposed issue of securities - TYP
21 Aug 09:30
 
Landmark EEG Biomarker Agreement for Precision Psychiatry
21 Aug 08:58
 
Application for quotation of securities - TYP
13 Aug 15:50
 
$2.6m in non-dilutive capital funding secured
12 Aug 08:29
 
View More arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
3.4¢
Change
0.002(6.25%)
Mkt cap ! $47.24M
Open High Low Value Volume
3.3¢ 3.4¢ 3.2¢ $70.72K 2.135M

Buyers (Bids)

No. Vol. Price($)
3 1882923 3.3¢
 

Sellers (Offers)

Price($) Vol. No.
3.4¢ 6693 1
View Market Depth
Last trade - 15.56pm 29/08/2025 (20 minute delay) ?
TYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.